(Q73802870)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320984%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Virchow's triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320984%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

A D Blann

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320984%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

G Y Lip

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320984%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320984%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320984%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320984%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320984%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

321-327

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320984%20AND%20SRC:MED&resulttype=core&format=json

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

von Willebrand factor antigen and fibronectin in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Levels of plasma thrombomodulin are increased in atheromatous arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Serum thrombomodulin. A novel marker of disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Increased levels of plasma thrombomodulin are associated with vascular and all-cause mortality in patients on long-term anticoagulant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Hypothesis: is soluble P-selectin a new marker of platelet activation?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

β-Thromboglobulin, Platelet Production Time and Platelet Function in Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Evaluation of β thromboglobulin levels in cancer patients : Effects of antitumor chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Plasma levels of beta-thromboglobulin and factor VIII-related antigen in diabetic children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Platelet aggregation, coronary artery disease progression and future coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

New approaches to antiplatelet therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Fibrinogen and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Fibrin D-dimer: a useful clinical marker of thrombogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Markers of a hypercoagulable state following acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Impaired fibrinolysis and the risk for coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Significance of raised plasma concentrations of tissue-type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Effects of enalapril on tissue factor in patients with uncomplicated acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

Soluble P-selectin and the risk of future cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900419-9

7 January 2021

10.1016/S0049-3848(00)00419-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320984%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference